Fixation time does not affect the expression of estrogen receptor.

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype. BMC Cancer (2013) 0.75

Fixation time does not affect the expression of estrogen receptor. Am J Clin Pathol (2011) 0.75

Fixation time does not affect expression of HER2/neu: a pilot study. Am J Clin Pathol (2010) 2.05

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging (2003) 1.40

Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. Am J Surg (2002) 1.11

Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells. Int J Biochem Cell Biol (2004) 1.02

In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer. Gynecol Oncol (2004) 0.98

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer. BMC Cancer (2013) 0.89

Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffin-embedded tissue specimens. J Clin Pathol (2010) 0.89

Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma. Ann Surg Oncol (2009) 0.84

Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions. Mod Pathol (2003) 0.77

Fixation time and HER2/neu assessment. Am J Clin Pathol (2011) 0.75

Discrimination of breast cancer by anti-malignin antibody serum test in women undergoing biopsy. Cancer Epidemiol Biomarkers Prev (2005) 0.75